Our Services Your Success
Helping clients be appropriately aggressive, yet compliant. ™What Clients Say?
FDA: 510(k) Pathway Survey 2022
Ten years ago, DuVal & Associates and Introworks sent out an industry survey to obtain feedback and share insights on medtech industry's experience working with FDA on the 510(k) program. A lot has changed since then, and we have done it again. This time NAMSA joined our sponsorship. Round two of the survey was completed earlier in 2022. The survey gave us a chance to solicit industry's input on how the FDA is doing. Use the options below to view both the results of the survery and a webinar hosted by DuVal & Associates and Introworks that discusses the results of the survey with strategic insight from our senior regulatory and legal professionals.
Survey Results Survey Webinar